What to Know About mFlusiva, the New mRNA Flu Vaccine
For the first time, adults age 50 and older in the United States can get an mRNA flu vaccine. The U.S. Food and Drug Administration (FDA) approved mFlusiva®, the first mRNA flu vaccine, in August 2026. Moderna makes mFlusiva. It uses the same basic vaccine technology...
Exercise May Give Your Immune System a Boost
Vaccines and nutrition strengthen your immunity to viruses and other harmful pathogens—exercise may give it an even bigger boost. In this Q&A, Christine Schindler, MD, Assistant Professor of Medicine (General Internal Medicine), Icahn School of Medicine at Mount...
Mount Sinai Researchers Share Thoughts on the Promise of mRNA Technology, a Nobel Prize-Winning Science
The 2023 Nobel Prize in Medicine was awarded jointly to two researchers, Katalin Karikó, PhD, and Drew Weissman, MD, PhD, for their decades-long work on messenger RNA (mRNA), which ultimately led to the successful development of COVID-19 vaccines that made a huge...
Delivering the Future of Vaccines With mRNA Technology
One of the great tools that helped turned the tide of the COVID-19 pandemic was the use of vaccines, especially those based on messenger RNA (mRNA) technology. Such vaccines use molecules that teach the cells in the body to generate proteins used by viruses or cancers, allowing the body’s immune system to recognize and fight off future infections.
What You Need to Know About the Latest COVID-19 Variant
You may have noticed that more people you know have gotten COVID-19 recently. One reason is the virus that causes COVID-19 continues to evolve into variants that are more contagious. The latest one is known as XBB.1.5, and since early December it has become the...
Here’s Why You Should Get a Flu Shot Now
With the arrival of fall, the weather is getting cooler, the days are getting short, and it’s time for your annual flu shot. Since the outbreak of the COIVD -19 pandemic, the presence of seasonal flu, caused by the influenza virus, has been lower than normal, as...